DiaMedica Therapeutics (DMAC) Stock Chart & Stock Price History $4.37 -0.06 (-1.35%) (As of 11/5/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DiaMedica Therapeutics Stock Price Performance5 Day Performance0.00%1 Month Performance+0.23%3 Month Performance+26.67%6 Month Performance+45.67%Year-To-Date Performance+53.87%1 Year Performance+72.05% Receive DMAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. DMAC Stock Chart for Tuesday, November, 5, 2024 DMAC Chart by TradingView DiaMedica Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/05/2024$4.43$4.37-1.35%$4.44$4.3526,869 shs$186.82 million11/04/2024$4.25$4.43+4.24%$4.44$4.2123,581 shs$189.38 million11/01/2024$4.37$4.25-2.75%$4.40$4.0569,362 shs$181.69 million10/31/2024$4.36$4.37+0.23%$4.48$4.1846,316 shs$186.81 million10/30/2024$4.32$4.36+0.93%$4.40$4.2624,059 shs$186.38 million10/29/2024$4.30$4.32+0.47%$4.40$4.3024,943 shs$184.67 million Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/28/2024$4.39$4.30-2.05%$4.44$4.2736,848 shs$183.79 million10/25/2024$4.34$4.39+1.27%$4.43$4.2640,098 shs$187.64 million10/24/2024$4.38$4.34-1.03%$4.36$4.1638,512 shs$185.29 million10/23/2024$4.30$4.38+1.86%$4.48$4.2351,091 shs$187.21 million10/22/2024$4.29$4.30+0.23%$4.30$4.2117,435 shs$183.79 million10/21/2024$4.34$4.29-1.15%$4.30$4.2312,945 shs$183.36 million10/18/2024$4.29$4.34+1.17%$4.36$4.2122,078 shs$185.50 million10/17/2024$4.40$4.29-2.50%$4.36$4.2724,808 shs$183.36 million10/16/2024$4.45$4.40-1.12%$4.45$4.3727,283 shs$188.07 million10/15/2024$4.46$4.45-0.22%$4.50$4.3829,528 shs$190.20 million10/14/2024$4.25$4.46+4.94%$4.50$4.3071,575 shs$190.63 million10/11/2024$4.42$4.25-3.85%$4.49$4.1817,766 shs$181.69 million10/10/2024$4.50$4.42-1.78%$4.50$4.3689,950 shs$188.92 million10/09/2024$4.65$4.50-3.23%$4.77$4.40117,743 shs$192.34 million10/08/2024$4.37$4.65+6.41%$4.67$4.38171,015 shs$198.75 million10/07/2024$4.36$4.37+0.23%$4.46$4.3231,886 shs$186.78 million10/04/2024$4.39$4.36-0.68%$4.46$4.2228,672 shs$186.36 million10/03/2024$4.45$4.39-1.35%$4.45$4.3619,236 shs$187.64 million10/02/2024$4.23$4.45+5.20%$4.48$4.1887,535 shs$190.20 million10/01/2024$4.19$4.23+0.95%$4.23$4.1130,616 shs$180.80 million09/30/2024$4.18$4.19+0.24%$4.30$4.1522,968 shs$179.09 million09/27/2024$4.30$4.18-2.79%$4.29$4.1631,659 shs$178.66 million09/26/2024$4.14$4.30+3.86%$4.31$4.1532,706 shs$183.83 million09/25/2024$4.03$4.14+2.73%$4.25$4.0434,823 shs$176.99 million09/24/2024$4.01$4.03+0.50%$4.16$3.8680,677 shs$172.25 million09/23/2024$4.13$4.01-2.91%$4.18$4.0152,731 shs$171.40 million09/20/2024$4.04$4.13+2.23%$4.13$4.00188,021 shs$176.52 million09/19/2024$4.13$4.04-2.18%$4.20$3.9961,882 shs$172.68 million09/18/2024$4.35$4.13-5.06%$4.48$3.9877,192 shs$176.52 million09/17/2024$4.49$4.35-3.12%$4.51$4.3519,868 shs$185.93 million09/16/2024$4.50$4.49-0.22%$4.72$4.4544,702 shs$191.91 million09/13/2024$4.29$4.50+4.90%$4.95$4.23188,810 shs$192.34 million09/12/2024$4.38$4.29-2.05%$4.40$4.2032,561 shs$183.36 million09/11/2024$4.19$4.38+4.53%$4.49$4.14113,458 shs$187.21 millionBlackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW09/10/2024$4.14$4.19+1.21%$4.19$4.0535,450 shs$179.09 million09/09/2024$4.03$4.14+2.73%$4.50$4.06159,061 shs$176.95 million09/06/2024$3.85$4.03+4.68%$4.07$3.8068,553 shs$172.25 million09/05/2024$3.96$3.85-2.78%$3.96$3.7652,835 shs$164.56 million09/04/2024$3.89$3.96+1.80%$3.99$3.8210,012 shs$169.29 million09/03/2024$3.93$3.89-1.02%$4.01$3.7925,285 shs$166.30 million09/02/2024$3.93$3.93$3.96$3.8414,500 shs$168.01 million08/30/2024$3.94$3.93-0.25%$3.96$3.8814,581 shs$167.98 million08/29/2024$3.99$3.94-1.25%$4.00$3.947,052 shs$168.40 million08/28/2024$3.95$3.99+1.01%$4.03$3.9429,660 shs$170.54 million08/27/2024$4.07$3.95-2.95%$4.06$3.8237,803 shs$168.83 million08/26/2024$4.00$4.07+1.75%$4.07$3.9235,808 shs$173.96 million08/23/2024$3.98$4.00+0.50%$4.00$3.8830,299 shs$170.97 million08/22/2024$3.70$3.98+7.57%$4.04$3.74122,886 shs$170.11 million08/21/2024$3.70$3.70$3.71$3.6021,662 shs$158.15 million08/20/2024$3.57$3.70+3.64%$3.71$3.5331,537 shs$158.15 million08/19/2024$3.60$3.57-0.83%$3.64$3.5052,345 shs$152.59 million08/16/2024$3.51$3.60+2.56%$3.60$3.4615,627 shs$153.87 million08/15/2024$3.48$3.51+0.86%$3.60$3.4313,529 shs$150.02 million08/14/2024$3.58$3.48-2.79%$3.59$3.4610,604 shs$148.74 million08/13/2024$3.53$3.58+1.42%$3.69$3.5222,842 shs$153.02 million08/12/2024$3.55$3.53-0.56%$3.77$3.5145,519 shs$150.88 million08/09/2024$3.35$3.55+5.97%$3.67$3.3849,032 shs$151.73 million08/08/2024$3.25$3.35+3.08%$3.40$3.2637,573 shs$143.19 million08/07/2024$3.35$3.25-2.99%$3.45$3.2525,943 shs$138.91 million08/06/2024$3.45$3.35-2.90%$3.51$3.2631,553 shs$143.18 million08/05/2024$3.31$3.45+4.23%$3.45$3.2857,179 shs$147.45 million Related Companies Ironwood Pharmaceuticals Stock Price Chart CorMedix Stock Price Chart Tourmaline Bio Stock Price Chart Oculis Stock Price Chart ABIVAX Société Anonyme Stock Price Chart Astria Therapeutics Stock Price Chart Y-mAbs Therapeutics Stock Price Chart Stoke Therapeutics Stock Price Chart Entrada Therapeutics Stock Price Chart Tango Therapeutics Stock Price Chart Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DMAC) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
